FACTS ABOUT NEW ADVANCEMENTS IN BRD4 INHIBITION THERAPY ABBV-744 REVEALED

In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing routine. Extra participants will likely be enrolled on the identified monotherapy dosign routine. In Segment B, members will obtain oral ruxolitinib and ABBV-744 will be specified as "insert-on" therapy. In Phase C, individuals will